SEATTLE, June 14, 2018 /PRNewswire/ -- CTI BioPharma Corp.
(CTI BioPharma) (NASDAQ: CTIC) today announced that management will
present at the JMP Securities 2018 Life Sciences Conference in
New York, NY on Thursday, June 21, 2018 at 1:00 PM ET.
The presentation will be webcast live and available for replay
from the Investors section of CTI BioPharma's website at
www.ctibiopharma.com.
About CTI BioPharma Corp.
CTI BioPharma Corp. is a biopharmaceutical company focused on
the acquisition, development and commercialization of novel
targeted therapies covering a spectrum of blood-related cancers
that offer a unique benefit to patients and healthcare providers.
CTI BioPharma has a late-stage development pipeline, including
pacritinib for the treatment of patients with myelofibrosis. CTI
BioPharma is headquartered in Seattle,
Washington. For additional information and to sign up for
email alerts and get RSS feeds, please visit
www.ctibiopharma.com.
CTI BioPharma Investor Contacts:
Julia Balanova
+1 646 378 2936
jbalanova@troutgroup.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-jmp-securities-2018-life-sciences-conference-300665994.html
SOURCE CTI BioPharma Corp.